Taurine protects HK-2 cells from oxidized LDL-induced cytotoxicity via the ROS-mediated mitochondrial and p53-related apoptotic pathways

Toxicol Appl Pharmacol. 2014 Sep 15;279(3):351-363. doi: 10.1016/j.taap.2014.06.029. Epub 2014 Jul 10.

Abstract

Oxidized LDL (oxLDL) induces a pro-oxidative environment and promotes apoptosis, causing the progression of renal diseases in humans. Taurine is a semi-essential amino acid in mammals and has been shown to be a potent endogenous antioxidant. The kidney plays a pivotal role in maintaining the balance of taurine. However, the mechanisms underlying the protective effects of taurine against oxLDL-induced injury in renal epithelial cells have not been clarified. In the present study, we investigated the anti-apoptotic effects of taurine on human proximal tubular epithelial (HK-2) cells exposed to oxLDL and explored the related mechanisms. We observed that oxLDL increased the contents of ROS and of malondialdehyde (MDA), which is a lipid peroxidation by-product that acts as an indicator of the cellular oxidation status. In addition, oxLDL induced cell death and apoptosis in HK-2 cells. Pretreatment with taurine at 100 μM significantly attenuated the oxLDL-induced cytotoxicity. We determined that oxLDL triggered the phosphorylation of ERK and, in turn, the activation of p53 and other apoptosis-related events, including calcium accumulation, destabilization of the mitochondrial permeability and disruption of the balance between pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins. The malfunctions induced by oxLDL were effectively blocked by taurine. Thus, our results suggested that taurine exhibits potential therapeutic activity by preventing oxLDL-induced nephrotoxicity. The inhibition of oxLDL-induced epithelial apoptosis by taurine was at least partially due to its anti-oxidant activity and its ability to modulate the ERK and p53 apoptotic pathways.

Keywords: Apoptosis; HK-2 cells; ROS; Taurine; oxLDL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants*
  • Apoptosis / physiology*
  • Blotting, Western
  • Calcium Signaling / drug effects
  • Caspase 3 / metabolism
  • Cell Line
  • Cell Survival / drug effects
  • DNA / biosynthesis
  • DNA / genetics
  • Epithelial Cells
  • Humans
  • In Situ Nick-End Labeling
  • Kidney / cytology
  • Kidney / drug effects
  • Lipid Peroxidation / drug effects
  • Lipoproteins / isolation & purification
  • Lipoproteins / metabolism
  • Lipoproteins, LDL / antagonists & inhibitors*
  • Lipoproteins, LDL / toxicity*
  • Membrane Potential, Mitochondrial / drug effects
  • Microscopy, Confocal
  • Mitochondria / drug effects*
  • Mitochondria / physiology*
  • Reactive Oxygen Species / metabolism*
  • Signal Transduction / physiology*
  • Superoxide Dismutase / metabolism
  • Taurine / pharmacology*
  • Tumor Suppressor Protein p53 / physiology*

Substances

  • Antioxidants
  • Lipoproteins
  • Lipoproteins, LDL
  • Reactive Oxygen Species
  • Tumor Suppressor Protein p53
  • oxidized low density lipoprotein
  • Taurine
  • DNA
  • Superoxide Dismutase
  • Caspase 3